CHA Medical Gruop(representative: Kwang Yul Cha) wiill bring hope to incurable disease treatment.

Stem Cell; Core Technology of Biotechnology.

-Built 'CHA Group Stem Cell Institute' constitute of Nationally and Internationally well-known 180 scholars.

-Planning to build 'CHA Institute' in 'Pangyo Techno Valley' in 2010

-Lead the Cell Therapy Product Market using Stem cell, produce patient-specific stem cell and develop treatment method

College of Medicine, Pochon CHA University (Representative : Kwang Yul Cha M.D) / CHA Medical Group's biotechnology venture business, CHABiotec (Board of Director: Kwang Yul Cha) was established for the development of cell therapy using stem cell that is so-calld the "Flower of the Medical Science" in Septemberm 2000. Biotec is now promoting to form large-scale stem cell institute in both U.S and Korea by building CHA Medical Stem Cell Institute organized of 180 professionals focusing on stem cell treatment and cord blood deposit and transplantation. CHA MediGroup (representative: Kwang Yul Cha) will start constructing 'CHA Institute' in 2009 at Pangyo Techno Valley and it is scheduled to open in 2010

CHA Medical Group(representative: Kwang Yul Cha)

- We possess the best technology!

Stem Cell Production Capacity (Holding 12 Embryonic Stem Cell )

CHA Medical Group (representative: Kwang Yul Cha) created total 12 Human Embryonic Stem Cell and under the admission of the International Stem Cell Deliberate Council, CHA Medical Group is planning to produce over 100 embryonic stem cell that are able to apply clinical demonstration using human supporting cell, serum and non-serum culture medium at GMP within 10 years.

World known cytogenesis capacity/ability.

CHA Medical Group(representative: Kwang Yul Cha) is the first to success in recovering the damage of cranial nerves by transplanting the mice's embyonic stem cell into alive one's brain. Developed differentiation technology by using neuron, vascular Endothelial, Cartilage Cell, Endocrine Cell, and Heart muscle cells.

Gene Manipulation in Human embryonic stem cell

By developing technology that can induct specific gene into Human Embryonic Cell CHA Medical Group achieved cytogeny technology in specific cell, Human Embryonic Stem Cell production, medicinal screening method, Tumor Suppressor Technology, and interpreting the function of thepecific gene.

Gene Therapy ability

Found cancer cell suppressor protein and enzyme gene called 'mHAUSP' that operates the cancer-suppressing activity. Now researches on therapy and clinical test on progressing.

Artificial organ production ability.

By Utilizing embryonic stem call and adult stem cell developed biodegradable tissue, instestine and Scaffold, Researches on three-dimensional artificial tissue and intestine production is in advance.

CHA Medical Group(representative: Kwang Yul Cha)

- There's brigh future in Stem Cell !

Leading the Cell Therapy Product market using stem cell

If applied-technology such as cytogenesis and cell therapy utilizing embryonic stem cell is practically use, size of over 600 billion won market will be created. To treat specific diseases( Leukemia, Diabetes, urinary incontinece, stroke) cell differentiation inducement and establishing stem cell lines bank using Embryonic Stem Cell and Adult Stem Cell is promoted

Researches on Sterility & Stem Cell Security is guarantteed by running 'Human Ovum Freezing Bank'

'Slushed-Nitrogen Ovum Freezing Method' has survival rate over 90 percents and pregnancy rate is over over 65%, too. The method described above is known as world's best technology that has similiar reproduction ability to general ovum. CHA Biotec(Board of Director:Kwang Yul Cha) became the leader of this field by steadily executing safe and moral stem cell and medical treatment on sterility by running freezing bank.shed-Nitrogen Ovum Freezing Method' has survival rate over 90 percents and pregnancy rate

CHA Regenerative Medical Institute, awarded the grant "Patient-Specific Stem Cell Production"
Awarded the grant related to patient-specific stem cell production using somac cell reproduction from WIRB in June, 2006. Using Human ovum Freezing Bank , developing patient-specific stem cell production and treatment techonology is their aim.

The 5th Pacific Rim Society for Fertility and Sterility(Chairman: Kwang Yul Chav

College of Medicine, Pochon CHA University (representative: Kwang Yul Cha M.D) held “The 5th Pacific Rim Society for Fertility and Sterility(Chairman: Kwang Yul Cha)” in Dynasty Hall, Seoul Shilla Hotel from June 9th ~ 10th to conquer the low birth late, inviting the world’s foremost scholars in the field of sterilization and reproductive medicine.
The professors including Kwang-Yul Cha M.D from CHA Medical Group read papers in their sophisticated field.

“The 5th Pacific Rim Society for Fertility and Sterility(Chairman: Kwang Yul Cha)” held by CHA Medical Group is hosted by three leading institute; The Korean Society of Fertility & Sterility, The Korean Society of preservation reproduction medicine, and The Korean Society of Developmental Biology. Nationally and internationally well-known authorities on the field of Sterilization and reproductive medicine from Korea, United States, and Japan announced their papers and about 500 participants from Thailand, India, Vietnam and Nepal enlighten the conference.

At first day of the conference, the chairman Kwang Yul Cha read the paper “ Slush Nitrogen Ovum Freezing method” that received “The Best Paper Award” from “World Society for Reproductive Medicine” and the head manager of Stem Cell Institute, Hyung-Min Jung made presentation over embryonic cell and was greeted enthusiastically by the participants.
The survival rate of ovum is about 50 percents when applying the Existing Ovum Freezing Method. On the other hand, Slush-Nitrogen Ovum Freezing Method raises the survival rate to over 90 percents that it initiated the way to activate the ovum bank.

At the second day, Tae-ki Yoon from the Obstetrici research center read the paper that received “The Best Paper Award” from “The World Society of Fertility & Sterility”. In 11th, participants listen to a lecture describing “Freezing method” and practiced freezing method using a culture fluid and egg cell of a rat before noon. At afternoon, 21 participants divided into 7 groups and exercised the principles they learned from the previous lecture. The participants showed great enthusiasm toward the subject throughout the conference and spent meaningful time.

※About Kwang Yul Cha, MD, PhD
-MD, Yonsei University School of Medicine
-PhD, Pochon CHA University College of Medicine
-Reproductive Endocrinology Specialist
-Fellowship, USC -Visiting Professor, Columbia University School of Medicine
-Chancellor, Pochon CHA University (present)
-CEO, CHA HEALTH SYSTEMS, Inc. (present)
-Chairman, Hollywood Presbyterian Medical Center (present)
-Director, CHA RMI (present)
-Co-Director, CHA Stem Cell Institute, Pochon CHA University College of Medicine (present)
-80 international papers and 200domestic papers, 15 books, 3 patents